Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The . gov means it’s official VSports app下载. Federal government websites often end in . gov or . mil. Before sharing sensitive information, make sure you’re on a federal government site. .

Https

The site is secure V体育官网. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. .

Meta-Analysis
. 2025 Sep:207:108700.
doi: 10.1016/j.lungcan.2025.108700. Epub 2025 Aug 4.

V体育ios版 - Immune checkpoint inhibitors for advanced non-small cell lung cancer with preexisting COPD and CT-defined emphysema: A systematic review and meta-analysis

Yixiao Zhang  1 , Jin Zhao  2 , Zhuo Ma  3 , Jiawen Yi  4 , Yuan Yuan  5 , Lu Lang  6 , Chen Zhang  7 , Min Zhu  8 , Yuhui Zhang  9
Affiliations
Free article
Meta-Analysis

Immune checkpoint inhibitors for advanced non-small cell lung cancer with preexisting COPD and CT-defined emphysema: A systematic review and meta-analysis

"VSports最新版本" Yixiao Zhang et al. Lung Cancer. 2025 Sep.
Free article

Abstract

Background: Preexisting chronic obstructive pulmonary disease(COPD) and Computed Tomography(CT)-defined emphysema are associated with worse prognosis in patients with non-small cell lung cancer(NSCLC) receiving chemotherapy, but the impact of these comorbidities on patients undergoing immune checkpoint inhibitors(ICIs) remains largely unclear. VSports手机版.

Methods: Studies on the safety and efficacy outcomes among advanced NSCLC with preexisting COPD and CT-defined emphysema receiving ICIs from various databases up to August 2024 were collected V体育安卓版. The number of events, as well as pooled effect size [odds ratio(OR) and hazard ratio (HR)] and 95% confidence intervals (CIs) were obtained. .

Results: A total of 21 studies (7 on efficacy, 11 on safety, and 3 on both) were included. Meta-analysis revealed the pooled overall response rate (ORR) and pooled disease control rate (DCR) were 38% and 62%, respectively. Compared to patients without preexisting COPD and CT-defined emphysema, the pooled OR for ORR and DCR was 1. 88 (95% CI, 1. 45-2. 44) and 2. 23 (95% CI, 1. 67-2. 98), without heterogeneity. COPD and CT-defined emphysema were also associated with better progression-free survival (HR, 0. 63 [95% CI, 0. 50-0. 80]) and overall survival (HR, 0. 59 [95% CI, 0. 41-0. 88]). The pooled incidences of any grade and grade 3 or higher checkpoint inhibitor-related pneumonitis (CIP) were 20% and 6% in patients with preexisting COPD and CT-defined emphysema, which was significantly higher than that in those without these comorbidities (OR, 1. 97 [95% CI, 1. 41-2. 76]; OR, 2. 52 [95% CI, 1. 72-3. 70]) V体育ios版. Moreover, most cases of CIP (84. 0%) improved with ICIs discontinuation and/or the administration of corticosteroids. .

Conclusion: Preexisting COPD and CT-defined emphysema were associated with favorable clinical efficacy and increased risk of CIP in the immunotherapy era. Most cases of CIP are treatable and manageable. VSports最新版本.

Keywords: CT-defined emphysema; Chronic obstructive pulmonary disease; Immune checkpoint inhibitors; Non-small cell lung cancer V体育平台登录. .

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

MeSH terms

"V体育ios版" Substances

LinkOut - more resources